Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_assertion type Assertion NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_head.
- NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_assertion description "[These results show that the TrkB-BDNF pathway provides a survival advantage when exposed to DNA-damaging reagents, and, therefore, this autocrine pathway may play an important role in mediating the drug-resistant phenotype associated with TrkB-expressing neuroblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_provenance.
- NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_assertion evidence source_evidence_literature NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_provenance.
- NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_assertion SIO_000772 12438236 NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_provenance.
- NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_assertion wasDerivedFrom befree-20140225 NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_provenance.
- NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_assertion wasGeneratedBy ECO_0000203 NP287285.RAVDm1rOt-n28AuwUBAy4NVtDVgnm7TG1-G0bt_Va-NiE130_provenance.